{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T04:16:07Z","timestamp":1689826567696},"reference-count":14,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2023,7,1]]},"DOI":"10.1001\/jamadermatol.2023.1331","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T15:33:03Z","timestamp":1685547183000},"page":"697","source":"Crossref","is-referenced-by-count":0,"title":["Biosimilars for the Treatment of Psoriasis\u2014A Systematic Review of Clinical Trials and Observational Studies"],"prefix":"10.1001","volume":"159","author":[{"given":"Luigi","family":"Naldi","sequence":"first","affiliation":[{"name":"Centro Studi GISED, Bergamo, Italy"},{"name":"Department of Dermatology, AULSS8, Ospedale San Bortolo, Vicenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Addis","sequence":"additional","affiliation":[{"name":"Unit of Drug Epidemiology, Department of Epidemiology, Regione Lazio, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"key":"ded230008r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.1338","article-title":"Biosimilars for the treatment of psoriasis: a systematic review of clinical trials and observational studies.","author":"Phan","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"4","key":"ded230008r3","first-page":"24","article-title":"Defining the difference: what makes biologics unique.","volume":"1","author":"Morrow","year":"2004","journal-title":"Biotechnol Healthc"},{"issue":"4","key":"ded230008r4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/14737167.2019.1630274","article-title":"Tracking the price of existing biologics when drugs enter the market.","volume":"19","author":"Stiff","year":"2019","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"5","key":"ded230008r5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1056\/NEJMp1107285","article-title":"Developing the nation\u2019s biosimilars program.","volume":"365","author":"Kozlowski","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"ded230008r6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.amjms.2017.12.014","article-title":"Biosimilars for immune-mediated chronic diseases in primary care: what a practicing physician needs to know.","volume":"355","author":"Feldman","year":"2018","journal-title":"Am J Med Sci"},{"issue":"6","key":"ded230008r7","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s11739-020-02450-9","article-title":"Methodological aspects of superiority, equivalence, and non-inferiority trials.","volume":"15","author":"Stefanos","year":"2020","journal-title":"Intern Emerg Med"},{"issue":"1","key":"ded230008r8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00228-018-2542-1","article-title":"Regulation of biosimilar medicines and current perspectives on interchangeability and policy.","volume":"75","author":"O\u2019Callaghan","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"ded230008r9","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1016\/S2214-109X(22)00460-0","article-title":"Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities.","volume":"11","author":"Morin","year":"2023","journal-title":"Lancet Glob Health"},{"key":"ded230008r10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1057\/palgrave.jmm.5050125","article-title":"Branding: \u2018to brand or not to brand.\u2019","volume":"8","author":"Griffiths","year":"2008","journal-title":"J Med Mark"},{"issue":"5","key":"ded230008r11","first-page":"240","article-title":"Knowledge, perceptions, attitude, barriers and facilitators of biosimilars use across specialty physicians and hospital pharmacists: a national survey.","volume":"45","author":"Mar\u00edn-Jim\u00e9nez","year":"2021","journal-title":"Farm Hosp"},{"key":"ded230008r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.11.009","article-title":"The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems.","volume":"52","author":"Kvien","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"ded230008r13","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1377\/hlthaff.2021.00070","article-title":"Competition From biosimilars drives price reductions for biologics in the French Single-Payer Health System.","volume":"40","author":"Robinson","year":"2021","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"ded230008r14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40259-019-00365-2","article-title":"Challenges in post-marketing studies of biological drugs in the era of biosimilars: a report of the International Society for Pharmacoepidemiology 2019 mid-year meeting in Rome, Italy.","volume":"33","author":"Ingrasciotta","year":"2019","journal-title":"BioDrugs"},{"key":"ded230008r2","first-page":"129","volume-title":"FDA Regulatory Affairs: a Guide For Prescription Drugs, Medical Devices, and Biologics","author":"Kenimer","year":"2004"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2805558\/jamadermatology_naldi_2023_ed_230008_1689096805.38868.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T15:15:23Z","timestamp":1689779723000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2805558"}},"subtitle":["Looking Beyond Single-Trial Evidence for a Valuable Choice"],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2023.1331","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,1]]}}}